Incidental and symptomatic renal tumors

impact on patient survival

Authors

  • Marcos Francisco Dall’Oglio Hospital Sírio Libanês and Hospital Beneficência Portuguesa de São Paulo
  • Miguel Srougi Hospital Sírio Libanês and Hospital Beneficência Portuguesa de São Paulo
  • Pierre Damião Gonçalves Hospital Sírio Libanês and Hospital Beneficência Portuguesa de São Paulo
  • Kátia Leite Hospital Sírio Libanês and Hospital Beneficência Portuguesa de São Paulo
  • Luciano Nesrallah Hospital Sírio Libanês and Hospital Beneficência Portuguesa de São Paulo
  • Flávio Hering Hospital Sírio Libanês and Hospital Beneficência Portuguesa de São Paulo

Keywords:

Carcinoma, Renal, Cell, Diagnosis, Incidental, Survival

Abstract

CONTEXT: Renal cell carcinoma is the third most frequent genitourinary neoplasia, and there is currently an increase in the incidental diagnosis of tumors confined to the kidneys. OBJECTIVE: To study the survival of patients with incidental and symptomatic renal tumors who have undergone nephrectomy. DESIGN: Retrospective. SETTING: Hospital Sírio Libanês and Beneficência Portuguesa de São Paulo. PARTICIPANTS: 115 patients with diagnosis of renal cell carcinoma, operated on by the same group of surgeons and evaluated by a single pathologist. MAIN MEASUREMENTS: Sex, age and diagnosis method, analyzed in two groups, according to the tumor diagnosis: Group 1 with incidental diagnosis and Group 2 with symptomatic tumors. The anatomopathological characteristics and patient survival in both groups were evaluated. A statistical analysis was performed using the Student t, chi-squared, log rank and Kaplan-Meyer tests. RESULTS: Among the studied patients, 59(51%) had an incidental diagnosis, with 78% diagnosed by ultrasonography, 20% by computerized tomography scan and 2% during surgeries; 56 patients (49%) were symptomatic. Tumor locations were equally distributed between the two kidneys, and the surgery was conservative for 24% of the incidental and 9% of the symptomatic group. In the incidental group only one patient had tumor progression and there was no death, while in the symptomatic group there were 5 progressions and 10 deaths. The 5-year specific cancer-free survival was 100% in the incidental and 80% in the symptomatic group (p = 0.001) while the disease-free rate was 98% in the incidental and 62% in the symptomatic group (p < 0001). CONCLUSION: Incidental renal tumor diagnosis offers better prognosis, providing longer diseasefree survival.

Downloads

Download data is not yet available.

Author Biographies

Marcos Francisco Dall’Oglio, Hospital Sírio Libanês and Hospital Beneficência Portuguesa de São Paulo

MD, PhD in Urology. Attending doctor in the Departamento de Urologia, Universidade Federal de São Paulo/Escola Paulista de Medicina, São Paulo, Brazil.

Miguel Srougi, Hospital Sírio Libanês and Hospital Beneficência Portuguesa de São Paulo

MD. Professor of Urology at the Universidade Federal de São Paulo/Escola Paulista de Medicina, São Paulo, Brazil.

Pierre Damião Gonçalves, Hospital Sírio Libanês and Hospital Beneficência Portuguesa de São Paulo

MD, PhD in Urology. Universidade Federal de São Paulo/Escola Paulista de Medicina, São Paulo, Brazil.

Kátia Leite, Hospital Sírio Libanês and Hospital Beneficência Portuguesa de São Paulo

MD, PhD in Pathology. Universidade Federal de São Paulo/Escola Paulista de Medicina, São Paulo, Brazil.

Luciano Nesrallah, Hospital Sírio Libanês and Hospital Beneficência Portuguesa de São Paulo

MD, PhD in Urology. Attending doctor in the Departamento de Urologia, Universidade Federal de São Paulo/Escola Paulista de Medicina, São Paulo, Brazil.

Flávio Hering, Hospital Sírio Libanês and Hospital Beneficência Portuguesa de São Paulo

MD, PhD in Urology. Attending doctor in the Departamento de Urologia, Universidade Federal de São Paulo/Escola Paulista de Medicina, São Paulo, Brazil.

References

Vogelzang NJ, Stadler WM. Kidney cancer. Lancet 1998;352:1691-6.

Chow WH, Devesa SS, Warren JL, Fraumeni JF. Rising inci- dence of renal cell cancer in the United States. JAMA 1999;281:1628-31.

Pisani P, Parkin DM, Ferlay J. Estimates of the worldwide mor- tality from eighteen major cancers in 1985. Implications for prevention and projections of future burden. Int J Cancer 1993;55:891-903,

Ries LAG, Kosary CK, Hankey BF, Miller BA, Edwards BK. SEER Cancer Statistics Review, 1973-1994, National Cancer Institute. NIH Publication No. 97-2789. Bethesda, National Institute of Health, 1997.

Skinner DG, Colvin RB, Vermillion CD, Pfister RC, Leadbetter WF. Diagnosis and management of renal cell carcinoma. A clini- cal and pathologic study of 309 cases. Cancer 1971;28:1165-77.

Chisholm GD, Roy RR. The systemic effects of malignant re- nal tumors. Br J Urol 1971;43:687-700.

Patel NP, Lavengood RW. Renal cell carcinoma: natural history and results of treatment. J Urol 1978;119:722-6.

Sweeney JP, Thornhill JA, Grainger R, McDermott TE, Butler MR. Incidentally detected renal cell carcinoma: pathological features, survival trends and implications for treatment. Br J Urol 1996;78:351-3.

Tsui KH, Shvarts O, Smith RB, Figlin R, deKernion JB, Belldegrun A. Renal cell carcinoma: prognostic significance of incidentally detected tumors. J Urol 2000;163:426-30.

Rodriguez-Rubio FI, Díez-Caballero F, Martín-Marquina A, Abad JI, Berian JM. Incidentally detected renal cell carcinoma. Br J Urol 1996;78:29-32.

Tosaka A, Ohya K, Yamada K, et al. Incidence and properties of renal masses and asymptomatic renal cell carcinoma detected by abdominal ultrasonography. J Urol 1990;144:1097-9.

Licht MR, Novick AC, Goormastic M. Nephron-sparing sur- gery in incidental versus suspected renal cell carcinoma. J Urol 1994;152:39-42.

Thompson IM, Peek M. Improvement in survival of patients with renal cell carcinoma – the role of the serendipitously de- tected tumor. J Urol 1988;140:487-90.

Pantuck AJ, Zisman A, Belldegrun AS. The changing natural history of renal cell carcinoma. J Urol 2001;166:1611-23.

Ritchie AWS, Chisholm GD. The natural history of renal car- cinoma. Semin Oncol 1983;10:390-400.

Kovacs G. The value of molecular genetic analysis in the diag- nosis and prognosis of renal cell tumours. World J Urol 1994;12:64-8.

deKernion JB, Ramming KP, Smith RB. The natural history of metastatic renal cell carcinoma: a computer analysis. J Urol 1978;120:148-52.

Smith SJ, Bosniak MA, Megibow AJ, Hulnick DH, Horii SC, Raghavendra BN. Renal cell carcinoma: earlier discovery and increased detection. Radiology 1989;170:699-703.

Wolf JS. Evaluation and management of solid and cystic renal masses. J Urol 1998;159:1120-33.

Ritchie AW, deKernion JB. Incidental renal neoplasms: inci- dence in Los Angeles County, treatment and prognosis. Prog Clin Biol Res 1988;269:347-57.

Steinbach F, Stückle M, Griesinger A, et al. Multifocal renal cell tumors: a retrospective analysis of 56 patients treated with radical nephrectomy. J Urol 1994;152:1393-6.

Mukamel E, Konichezky M, Engelstein D, Servadio C. Inci- dental small renal tumors accompanying clinically overt renal cell carcinoma. J Urol 1988;140:22-4.

Nakano E, Iwasaki A, Seguchi T, et al. Incidentally diagnosed renal cell carcinoma. Eur Urol 1992;21:294-8.

Vallancien G, Torres LO, Gurfinkel E, Veillon B, Brisset JM. Incidental detection of renal tumours by abdominal ultrasonog- raphy. Eur Urol 1990;18:94-6.

Aso Y, Homma Y. A survey on incidental renal cell carcinoma in Japan. J Urol 1992;147:340-3.

Bretheau D, Lechevallier E, Eghazarian C, Grisoni V, Coulange C. Prognostic significance of incidental renal cell carcinoma. Eur Urol 1995;27:319-23.

Rousseau T, Peyret C, Zerbib M, Thiounn N, Flam T, Debre B. Circumstances of the detection of kidney cancer. Current part of accidental discoveries. J Urol 1994;100(4):189-95.

Bielsa O, Arango O, Carrasco N, et al. Incidental diagnosis of renal carcinoma. Impact on prognosis and survival. Actas Urol Esp 1996;20:601-4.

Tsukamoto T, Kumamoto Y, Yamazaki K, et al. Clinical analysis of incidentally found renal cell carcinomas. Eur Urol 1991;19:109-13.

Jayson M, Sanders H. Increased incidence of serendipitously discovered renal cell carcinoma. Urology 1998;51:203-5.

Ebert T, Owusu G, Strotmann P, Heydthausen M, Gerharz CD, Ackermann R. Do we need screening for renal cell carcinoma (RCC)? J Urol Suppl 1999;161:169, abstract 651.

Dinney CP, Awad SA, Gajewski JB, et al. Analysis of imaging modalities, staging systems, and prognostic indicators for renal cell carcinoma. Urology 1992;39:122-9.

Rodriguez R, Fishman EK, Marshall FF. Differential diagnosis and evaluation of the incidentally discovered renal mass. Semin Urol Oncol 1995;13(4):246-53.

Konnak JW, Grossman HB. Renal cell carcinoma as an inci- dental finding. J Urol 1985;134:1094-6.

Ueda T, Mihara Y. Incidental detection of renal carcinoma dur- ing radiological imaging. Br J Urol 1987;59:513-5.

Motzer RJ, Bander NH, Nanus DM. Renal-cell carcinoma. N Engl J Med 1996;335:865-75.

Ritchie AW, Kemp IW, Chisholm GD. Is the incidence of renal carcinoma increasing? Br J Urol 1984;56:571-3.

Curry NS, Schabel SI, Betsill WL. Small renal neoplasms: diag- nostic imaging, pathologic features, and clinical course. Radi- ology 1986;158:113-7.

Bosniak MA. The small (less than or equal to 3.0 cm) renal parenchymal tumor: detection, diagnosis, and controversies. Ra- diology 1991;179:307-17.

Amendola MA, Bree RL, Pollack HM, et al. Small renal cell carcinomas: resolving a diagnostic dilemma. Radiology 1988;166:637-41.

Lee CT, Katz J, Shi W, Thaler HT, Reuter VE, Russo P: Surgi- cal management of renal tumors 4 cm or less in a contemporary cohort. J Urol 2000;163: 730-6.

Hafez KS, Fergany AF, Novick AC. Nephron-sparing surgery for localized renal cell carcinoma: impact of tumor size on pa- tient survival, tumor recurrence and TNM staging. J Urol 1999; 162:1930-3.

Ljungberg B, Alamdari FI, Rasmuson T, Roos G. Follow-up guide- lines for nonmetastatic renal cell carcinoma based on the occurrence of metastases after radical nephrectomy. BJU Int 1999;84:405-11.

Downloads

Published

2002-11-11

How to Cite

1.
Dall’Oglio MF, Srougi M, Gonçalves PD, Leite K, Nesrallah L, Hering F. Incidental and symptomatic renal tumors: impact on patient survival. Sao Paulo Med J [Internet]. 2002 Nov. 11 [cited 2025 Mar. 19];120(6):165-9. Available from: https://periodicosapm.emnuvens.com.br/spmj/article/view/2733

Issue

Section

Original Article